Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BGB-5777 + Radiotherapy + unspecified PD-1 antibody |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BGB-5777 | BGB5777|BGB 5777 | IDO1 Inhibitor 12 Immune Checkpoint Inhibitor 153 | BGB-5777 inhibits indoleamine 2,3-dioxygenase 1 (IDO1) to prevent tryptophan breakdown in the tumor microenvironment, thereby activating a cytotoxic immune response against IDO1 expressing tumor cells (Neuro-Oncology, Volume 19, Issue suppl_4, 1 June 2017, Pages iv32, PMID: 29500275). | |
Radiotherapy | ||||
unspecified PD-1 antibody | Experimental PD-1 antibody | Immune Checkpoint Inhibitor 153 PD-L1/PD-1 antibody 100 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|